A Fighter Bigger Than Myeloma
1Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX.
Summary
Multiple myeloma disproportionately affects minority populations. This patient's journey highlights ongoing civil liberties issues in healthcare, emphasizing the need for continued progress in health equity.
Area of Science:
- Oncology
- Health Equity
- Civil Liberties in Medicine
Background:
- Multiple myeloma is a cancer of plasma cells, often exhibiting significant racial and ethnic disparities in incidence and outcomes.
- Addressing health disparities is crucial for equitable cancer care and patient advocacy.
Purpose of the Study:
- To illustrate the intersection of a multiple myeloma diagnosis with broader issues of civil liberties and health equity.
- To use a patient narrative to underscore progress and remaining challenges in healthcare equality.
Main Methods:
- A case study approach detailing a patient's experience with multiple myeloma.
- Qualitative analysis of the patient's journey in the context of civil liberties and healthcare access.
Main Results:
- The patient's diagnosis and treatment pathway revealed systemic inequities.
- The narrative serves as a powerful reminder of historical and contemporary civil liberties concerns in healthcare delivery.
Conclusions:
- Patient stories are vital for understanding the human impact of health disparities.
- Achieving true health equity in oncology requires ongoing commitment to civil liberties and social justice.
Related Concept Videos
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
02:07Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
02:56Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K